IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
复制标题

DOI:
10.1038/emboj.2013.203
复制
发表时间:
2013-10-16
期刊:
影响因子:
11.4
通讯作者:
Stark, George R.
Stark, George R.
中科院分区:
生物学1区
文献类型:
--
作者:
Cheon, HyeonJoo;Holvey-Bates, Elise G.;Schoggins, John W.;Forster, Samuel;Hertzog, Paul;Imanaka, Naoko;Rice, Charles M.;Jackson, Mark W.;Junk, Damian J.;Stark, George R.

文献摘要

参考文献

被引文献

相似文献

单次高剂量的干扰素-β(IFNβ)激活强大的细胞应答,其中许多抗病毒、促凋亡和抗增殖蛋白高度表达。由于这些蛋白质中的一些是有害的,细胞迅速下调这种初始反应。然而,许多无害的抗病毒蛋白质的表达是持续的,延长了初始抗病毒反应的相当大一部分,并提供了对DNA损伤的抵抗力。虽然转录因子ISGF 3(IRF 9和酪氨酸磷酸化的STAT 1和2)驱动第一个快速反应阶段,但由IFNβ诱导的高水平IRF 9和STAT 1和2(无酪氨酸磷酸化)形成的相关因子未磷酸化ISGF 3(U-ISGF 3)驱动第二个延长反应阶段。U-ISGF 3诱导的抗病毒基因显示出延长的表达,由不同的IFN刺激的应答元件(ISRE)驱动。细胞持续暴露于低水平的IFNβ(通常见于癌症),导致仅U-ISGF 3依赖性蛋白质的表达稳态增加,而其他IFNβ诱导的蛋白质没有持续增加,并导致对DNA损伤的组成性抗性。
A single high dose of interferon-β (IFNβ) activates powerful cellular responses, in which many anti-viral, pro-apoptotic, and anti-proliferative proteins are highly expressed. Since some of these proteins are deleterious, cells downregulate this initial response rapidly. However, the expression of many anti-viral proteins that do no harm is sustained, prolonging a substantial part of the initial anti-viral response for days and also providing resistance to DNA damage. While the transcription factor ISGF3 (IRF9 and tyrosine-phosphorylated STATs 1 and 2) drives the first rapid response phase, the related factor un-phosphorylated ISGF3 (U-ISGF3), formed by IFNβ-induced high levels of IRF9 and STATs 1 and 2 without tyrosine phosphorylation, drives the second prolonged response. The U-ISGF3-induced anti-viral genes that show prolonged expression are driven by distinct IFN stimulated response elements (ISREs). Continuous exposure of cells to a low level of IFNβ, often seen in cancers, leads to steady-state increased expression of only the U-ISGF3-dependent proteins, with no sustained increase in other IFNβ-induced proteins, and to constitutive resistance to DNA damage.
DOI: 10.1186/1471-2407-9-102
发表时间: 2009-04-01
期刊: BMC cancer
影响因子: 3.8
作者:
Cai D;Cao J;Li Z;Zheng X;Yao Y;Li W;Yuan Z
通讯作者: Yuan Z
DOI: 10.1016/j.ccr.2010.10.013
发表时间: 2010-11-16
期刊: Cancer cell
影响因子: 50.3
作者:
Chen E;Beer PA;Godfrey AL;Ortmann CA;Li J;Costa-Pereira AP;Ingle CE;Dermitzakis ET;Campbell PJ;Green AR
通讯作者: Green AR
DOI: 10.1371/journal.pone.0005821
发表时间: 2009-06-08
期刊: PloS one
影响因子: 3.7
作者:
Khodarev NN;Roach P;Pitroda SP;Golden DW;Bhayani M;Shao MY;Darga TE;Beveridge MG;Sood RF;Sutton HG;Beckett MA;Mauceri HJ;Posner MC;Weichselbaum RR
通讯作者: Weichselbaum RR
DOI: 10.1038/ng1097
发表时间: 2003-03-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Dupuis, S;Jouanguy, E;Casanova, JL
通讯作者: Casanova, JL
DOI: 10.1158/1078-0432.ccr-07-4761
发表时间: 2008-10-01
影响因子: 11.5
作者:
Hatano, Hiroko;Kudo, Yasusei;Takata, Takashi
通讯作者: Takata, Takashi